A Hypercoagulable Hematological Metastasis Breast Cancer Model

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left">Sample</td><td class="align_center">Size(nm)</td><td class="align_center">Concentration</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left">PLT (24 h)</td><td class="align_center">82.36±28.29</td><td class="align_center">5.84×10<sup>9</sup></td></tr><tr><td class="align_left">4T1 + PLT (24 h)</td><td class="align_center">76.91±29.26</td><td class="align_center">9.86×10<sup>9</sup></td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td><div>PLT: platelets obtained from a BALB/c mouse. 4T1 + PLT: coculture of a murine breast cancer cell line and the PLTs obtained from the BALB/c mouse.<br/></div></td></tr></table>

<div>The procoagulant activity of the 24 h coculture supernatant was significantly higher than that of the 24 h platelets supernatant.</div>

BioMed Research International

A Hypercoagulable Hematological Metastasis Breast Cancer Model

Table 3